abrdn Healthcare Opportunities Fund (THQ) is a publicly traded Financial Services sector company. As of May 21, 2026, THQ trades at $18.53 with a market cap of $760.79M and a P/E ratio of 0.00. THQ moved +0.59% today. Year to date, THQ is -3.52%; over the trailing twelve months it is +0.00%. Its 52-week range spans $15.14 to $22.60. Rallies surfaces THQ's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading THQ stock inside the company?
Recent THQ insider activity includes DiMartino Rose bought 1.00K, Goetz Kathleen bought 600, Reit Todd bought 1.00K, Maher Bill bought 1.00K, and Goetz Kathleen bought 69.188. Rallies tracks insider transaction dates, shares, prices, and estimated values.
THQ Key Metrics
Key financial metrics for THQ
Metric
Value
Price
$18.53
Market Cap
$760.79M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.18%
52-Week High
$22.60
52-Week Low
$15.14
Volume
6
Avg Volume
0
Revenue (TTM)
$0
Net Income
$0
Gross Margin
0.00%
Recent THQ Insider Trades
DiMartino Rose bought 1.00K (~$21.30K) on Jul 16, 2024.
Goetz Kathleen bought 600 (~$11.72K) on Apr 9, 2024.
Reit Todd bought 1.00K (~$18.44K) on Jan 2, 2024.
Maher Bill bought 1.00K (~$18.25K) on Dec 28, 2023.
Goetz Kathleen bought 69.188 (~$1.50K) on Mar 23, 2022.
THQ analyst coverage data. Average price target: $0.00.
Common questions about THQ
Who is trading THQ stock inside the company?
Recent THQ insider activity includes DiMartino Rose bought 1.00K, Goetz Kathleen bought 600, Reit Todd bought 1.00K, Maher Bill bought 1.00K, and Goetz Kathleen bought 69.188. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for THQ?
Yes. Rallies tracks THQ insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is THQ research on Rallies investment advice?
No. Rallies provides research, data, and educational context for THQ. It does not provide personalized investment advice.
